These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Cellular carcinogenesis in preleukemic conditions:drivers and defenses. Ueda K; Ikeda K Fukushima J Med Sci; 2024 Jan; 70(1):11-24. PubMed ID: 37952978 [TBL] [Abstract][Full Text] [Related]
16. [Significance of cytogenetic studies in the preleukemias]. Sedginidse AG; Abduschelischwili RG Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):624-9. PubMed ID: 2448201 [TBL] [Abstract][Full Text] [Related]
17. Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II. Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival in a total series of 55 patients. Pedersen-Bjergaard J; Philip P; Pedersen NT; Hou-Jensen K; Svejgaard A; Jensen G; Nissen NI Cancer; 1984 Aug; 54(3):452-62. PubMed ID: 6733676 [TBL] [Abstract][Full Text] [Related]
18. A hypothesis regarding the development of acute myeloid leukemia from preleukemic disorders. The role of protooncogenes. Preisler HD Cancer Genet Cytogenet; 1988 May; 32(1):133-42. PubMed ID: 3162703 [TBL] [Abstract][Full Text] [Related]
19. [Preleukemic disorders]. Yoshida Y; Oguma S; Uchino H Gan To Kagaku Ryoho; 1989 Feb; 16(2):149-55. PubMed ID: 2645830 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of chromosome studies in cancer. Nowell PC Ann Clin Lab Sci; 1974; 4(4):234-40. PubMed ID: 4533399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]